IDEXX Laboratories, Inc. Net Income for the Trailing 12 Months (TTM) ending March 31, 2025: USD 894.97 M

IDEXX Laboratories, Inc. Net Income is USD 894.97 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 3.28% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • IDEXX Laboratories, Inc. Net Income for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 866.57 M, a 23.94% change year over year.
  • IDEXX Laboratories, Inc. Net Income for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 699.18 M, a -4.82% change year over year.
  • IDEXX Laboratories, Inc. Net Income for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 734.55 M, a 8.95% change year over year.
  • IDEXX Laboratories, Inc. Net Income for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 674.21 M, a 54.33% change year over year.
Key Data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Selling, General, and Administrative Expenses (SG&A)